Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

0.0940 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermtech Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Recap: DermTech Q1 Earnings
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.77% over the past year to ($0... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
DermTech to Announce Second Quarter Financial Results on August 4, 2021
From DermTech, Inc.
Via Business Wire
DermTech Announces New San Diego Headquarters
From DermTech, Inc.
Via Business Wire
This Medical Device Company Is Changing the Game in Skin Cancer
And it's on sale right now. 
Via The Motley Fool
Cramer Weighs In On FireEye, 3D Systems, More
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed he prefers Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Palo Alto Networks Inc (... 
Via Benzinga
DermTech Announces New Appointment of Monica Tellado to its Board of Directors
From DermTech, Inc.
Via Business Wire
DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category
From DermTech, Inc.
Via Business Wire
DermTech to Partner with University of Barcelona for Research Study on Atopic Dermatitis and Psoriasis
From DermTech, Inc.
Via Business Wire
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
DermTech Announces Three New Key Leadership Appointments: Chief Medical Officer, Vice President, Sales and Vice President, Information Technology and Digital Systems
From DermTech, Inc.
Via Business Wire
DermTech Announces Three New Scientific Advisory Board Members
From DermTech, Inc.
Via Business Wire
8 Stocks With The Highest Short Percent Of Float Right Now
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size... 
Via Benzinga
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
What Investors Should Look for With Exelixis, DermTech, and Teladoc Health
All three healthcare stocks could have solid growth prospects. 
Via The Motley Fool
DermTech Management to Participate in Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
High Flyers At Much Lower Altitudes
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
Via Talk Markets
28 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:... 
Via Benzinga
74 Biggest Movers From Friday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
Via Benzinga
13 Stocks Moving In Thursday's After-Hours Session
Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher... 
Via Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week... 
Via Benzinga
DermTech Reports First Quarter 2021 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Management to Present at the UBS Global Healthcare Virtual Conference
From DermTech
Via Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit
From DermTech, Inc.
Via Business Wire
3 Stocks I Fully Expect to Double or More Within the Next 5 Years
The prospects of great returns look really good for these stocks. 
Via The Motley Fool
DermTech to Announce First Quarter Financial Results on May 13, 2021
From DermTech, Inc.
Via Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams
From DermTech
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.